Supply report · August 2026 register copy
Hypertension in Nigeria: the registration data
Across the 8 hypertension molecules Ogbogwu tracks, our August 2026 copy of the NAFDAC Greenbook lists 280 active registrations held by 116 companies — plus 299 registrations recorded as no longer active. Every figure on this page is quoted from that dated copy; the register can change after our copy is taken.
- Active registrations
- 280
- Companies
- 116
- New in the last 12 months
- 31
- Renewals due within a year
- 66
Who holds the registrations
The ten companies with the most active hypertension registrations in our copy. The registrant is the NAFDAC applicant of record — for imported lines this is often the Nigerian distributor, not the factory.
- 1.Fensyl MHP Consulting— 8 active
- 2.First J. Pocco Pharmacy— 8 active
- 3.Embassy Pharmaceutical and Chemicals— 7 active
- 4.Me Cure Industries— 7 active
- 5.Swiss Pharma Nigeria— 7 active
- 6.ZMC International— 7 active
- 7.May & Baker— 6 active
- 8.Afrab-Chem— 5 active
- 9.Evans Therapeutics— 5 active
- 10.Ladfield Global Resources— 5 active
Where the products are made
Maker country as the register records it, across the 280 active registrations.
- India— 200 (71%)
- Nigeria— 37 (13%)
- Germany— 11 (4%)
- China— 8 (3%)
- Ireland— 6 (2%)
- Pakistan— 5 (2%)
- Bangladesh— 3 (1%)
- Italy— 3 (1%)
Dosage forms
- Tablet— 269 active
- Solution for injection— 6 active
- Caplet— 4 active
- Prolonged-release tablet— 1 active
Newest registrations
The latest hypertension approvals in our copy — 31 products were registered in the twelve months to August 2026.
- ANYI-TEX TELMISARTAN 40MG TABLETS — C4-1226, approved 2026-03-31
- Odizat HCT 10/160/12.5 mg Tablets — A4-101743, approved 2025-11-26
- Odizat HCT 10/160/25 mg Tablets — A4-101744, approved 2025-11-26
- NOVARTIS Exforge HCT 5-160-25mg Tablets — A4-5824, approved 2025-11-26
- Atenomel-100 Tablets — B4-6202, approved 2025-11-26
66 active registrations carry expiry dates within the next twelve months. A registration expiry means a renewal is due, not that the product disappears — holders routinely renew — but a lapsed number on a pack is worth checking before a large order. See which ones, by month →
The molecules behind these numbers
- Amlodipine — 63 active registrations
- Lisinopril — 47 active registrations
- Losartan — 34 active registrations
- Telmisartan — 30 active registrations
- Atenolol — 10 active registrations
- Furosemide — 10 active registrations
- Nifedipine — 7 active registrations
- Labetalol — 2 active registrations
“Hypertension” on this page means these molecules — the register itself has no therapeutic grouping, so a category page must say exactly what it counted.
The most-supplied presentations
- Amlodipine 10 mg tablet — 36 companies
- Amlodipine 5 mg tablet — 26 companies
- Lisinopril 10 mg tablet — 24 companies
- Lisinopril 5 mg tablet — 21 companies
- Telmisartan 40 mg tablet — 17 companies
- Losartan 50 mg tablet — 15 companies
Manufacturing or exporting hypertension medicines?
This is the market you'd be entering. See what NAFDAC registration and import into Nigeria require, and talk to us about distribution.
Supply the Nigerian marketOther supply reports
This page quotes the public NAFDAC Greenbook as of our dated copy, across the molecules Ogbogwu tracks in this category. It is a record of registrations, not market-share or sales data, and not an endorsement of any product. Registration status can change; for decisions that matter, confirm on the official Greenbook.